Cargando…

Nonlinear changes in delayed functional network topology in Alzheimer’s disease: relationship with amyloid and tau pathology

BACKGROUND: Alzheimer’s disease is a neurodegenerative disorder associated with the abnormal deposition of pathological processes, such as amyloid-ß and tau, which produces nonlinear changes in the functional connectivity patterns between different brain regions across the Alzheimer’s disease contin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mijalkov, Mite, Veréb, Dániel, Canal-Garcia, Anna, Hinault, Thomas, Volpe, Giovanni, Pereira, Joana B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273754/ https://www.ncbi.nlm.nih.gov/pubmed/37328909 http://dx.doi.org/10.1186/s13195-023-01252-3

Ejemplares similares

Directed Functional Brain Connectivity is Altered in Sub-threshold Amyloid-β Accumulation in Cognitively Normal Individuals
por: Mijalkov, Mite, et al.
Publicado: (2023)

Multiplex connectome changes across the alzheimer’s disease spectrum using gray matter and amyloid data
por: Canal-Garcia, Anna, et al.
Publicado: (2022)

Delayed correlations improve the reconstruction of the brain connectome
por: Mijalkov, Mite, et al.
Publicado: (2020)

Sex differences in multilayer functional network topology over the course of aging in 37543 UK Biobank participants
por: Mijalkov, Mite, et al.
Publicado: (2023)

Functional gradients of the medial parietal cortex in a healthy cohort with family history of sporadic Alzheimer’s disease
por: Veréb, Dániel, et al.
Publicado: (2023)

Directed Brain Connectivity Identifies Widespread Functional Network Abnormalities in Parkinson’s Disease
por: Mijalkov, Mite, et al.
Publicado: (2021)

Dendritic spines are lost in clusters in Alzheimer’s disease
por: Mijalkov, Mite, et al.
Publicado: (2021)

Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive Impairment and Alzheimer's Disease
por: Pereira, Joana B., et al.
Publicado: (2016)

BRAPH: A graph theory software for the analysis of brain connectivity
por: Mijalkov, Mite, et al.
Publicado: (2017)

Age-related differences in the functional topography of the locus coeruleus: implications for cognitive and affective functions
por: Veréb, Dániel, et al.
Publicado: (2023)

Age-related differences in the functional topography of the locus coeruleus and their implications for cognitive and affective functions
por: Veréb, Dániel, et al.
Publicado: (2023)

Amyloid Network Topology Characterizes the Progression of Alzheimer’s Disease During the Predementia Stages
por: Pereira, Joana B, et al.
Publicado: (2018)

Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
por: Pereira, Joana B, et al.
Publicado: (2021)

The Dichotomy of Alzheimer’s Disease Pathology: Amyloid-β and Tau
por: Ashford, J. Wesson
Publicado: (2019)

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
por: Ferrari-Souza, João Pedro, et al.
Publicado: (2022)

Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau Pathologies
por: Guedes, Joana R., et al.
Publicado: (2018)

Effects of a Highly Challenging Balance Training Program on Motor Function and Brain Structure in Parkinson’s Disease
por: Albrecht, Franziska, et al.
Publicado: (2021)

Brainstem tau pathology in Alzheimer’s disease is characterized by increase of three repeat tau and independent of amyloid β
por: Uematsu, Miho, et al.
Publicado: (2018)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
por: Mattsson‐Carlgren, Niklas, et al.
Publicado: (2021)

JNK Activation in Alzheimer’s Disease Is Driven by Amyloid β and Is Associated with Tau Pathology
por: Solas, Maite, et al.
Publicado: (2023)

Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease
por: Iaccarino, Leonardo, et al.
Publicado: (2017)

CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease
por: Barthélemy, Nicolas R., et al.
Publicado: (2023)

Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer’s disease
por: Pereira, Joana B, et al.
Publicado: (2020)

Elevated CSF GAP-43 is Alzheimer’s disease specific and associated with tau and amyloid pathology
por: Sandelius, Åsa, et al.
Publicado: (2018)

Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease
por: Mullins, Roger J., et al.
Publicado: (2017)

Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology
por: Sierksma, Annerieke, et al.
Publicado: (2020)

Islet amyloid polypeptide cross-seeds tau and drives the neurofibrillary pathology in Alzheimer’s disease
por: Zhang, Guoxin, et al.
Publicado: (2022)

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease
por: Bellaver, Bruna, et al.
Publicado: (2023)

A data-driven study of Alzheimer's disease related amyloid and tau pathology progression
por: Aksman, Leon M, et al.
Publicado: (2023)

APOEε4 potentiates the relationship between amyloid-β and tau pathologies
por: Therriault, Joseph, et al.
Publicado: (2020)

Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease
por: Milà-Alomà, Marta, et al.
Publicado: (2022)

Intercellular communication induces glycolytic synchronization waves between individually oscillating cells
por: Mojica-Benavides, Martin, et al.
Publicado: (2021)

New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer’s disease
por: Park, Sun Ah, et al.
Publicado: (2020)

The nonlinear relationship between cerebrospinal fluid Aβ(42) and tau in preclinical Alzheimer’s disease
por: de Leon, Mony J., et al.
Publicado: (2018)

Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease
por: Milà-Alomà, Marta, et al.
Publicado: (2022)

Amyloid β and Tau Alzheimer’s disease related pathology is reduced by Toll-like receptor 9 stimulation
por: Scholtzova, Henrieta, et al.
Publicado: (2014)

miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain
por: Salta, Evgenia, et al.
Publicado: (2016)

Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology
por: Kehoe, Patrick Gavin, et al.
Publicado: (2016)

Amyloid-β, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer’s disease
por: Frigerio, Irene, et al.
Publicado: (2021)

Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer’s disease
por: Guzmán-Vélez, Edmarie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4t61vdvj22r6s6h4410m0jc596